INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
HOUSE PTR/PurchaseVerified data

David J. Taylor bought MEDP

Self · Medpace Holdings, Inc. · Medpace Holdings, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
May 15, 2026
Disclosed
May 28, 2026
Disclosure timeline13 days from execution to publication · legal deadline 45 days
May 15 executedMay 28, 2026 disclosed

MEDP · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 13 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MEDP

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    36
    EP
    Ewald Stephen PGeneral Counsel & Corp. Secy.
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$859K
    1,245 sh
    		Oct 29, 2026Nov 2, 2026
    traded Oct 29, 2026
    		+4dSEC FORM 4

    Evidence

    46
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$10.87M
    16.1K sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    328 sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    12
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$55K
    328 sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    35
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$2.67M
    3,940 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$450K
    2,700 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    2,700 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    3,000 sh
    		Oct 12, 2026Oct 14, 2026
    traded Oct 12, 2026
    		+2dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$500K
    3,000 sh
    		Oct 12, 2026Oct 14, 2026
    traded Oct 12, 2026
    		+2dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$333K
    2,000 sh
    		Oct 7, 2026Oct 9, 2026
    traded Oct 7, 2026
    		+2dSEC FORM 4

    Evidence

    17
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    2,000 sh
    		Oct 7, 2026Oct 9, 2026
    traded Oct 7, 2026
    		+2dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$17.29M
    27.8K sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    29
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$10.11M
    16.1K sh
    		Sep 23, 2026Sep 25, 2026
    traded Sep 23, 2026
    		+2dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$30.79M
    49.0K sh
    		Sep 22, 2026Sep 23, 2026
    traded Sep 22, 2026
    		+1dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$13.64M
    21.9K sh
    		Sep 21, 2026Sep 23, 2026
    traded Sep 21, 2026
    		+2dSEC FORM 4

    Evidence

    42
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$2.38M
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    27
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$325K
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    27
    MP
    McCarthy Cornelius P. IIIDirector
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$690K
    1,140 sh
    		Aug 11, 2026Aug 13, 2026
    traded Aug 11, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MP
    McCarthy Cornelius P. IIIDirector
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    3,858 sh
    		Aug 7, 2026Aug 11, 2026
    traded Aug 7, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034650

    Timestamps

    Event (reported)
    May 15, 2026
    Published
    May 28, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    David J. Taylor
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    Medpace Holdings, Inc. - Common Stock
    Ticker
    MEDP
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    May 15, 2026
    Notification date (reported)
    May 28, 2026
    Days from execution to publication
    13

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    David J. Taylor reported a purchase of Medpace Holdings, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    David J. Taylorbioguide:T000490
    Issuer
    Medpace Holdings, Inc.cik:0001668397

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.